180 related articles for article (PubMed ID: 24020363)
1. Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure.
Berg M; Vanaerschot M; Jankevics A; Cuypers B; Maes I; Mukherjee S; Khanal B; Rijal S; Roy S; Opperdoes F; Breitling R; Dujardin JC
Mol Microbiol; 2013 Oct; 90(2):428-42. PubMed ID: 24020363
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
[TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani: genetic diversity of isolates from Sudan characterized by PCR-based RAPD.
Hamad SH; Khalil EA; Musa AM; Ibrahim ME; Younis BM; Elfaki ME; El-Hassan AM;
Exp Parasitol; 2010 Aug; 125(4):389-93. PubMed ID: 20346944
[TBL] [Abstract][Full Text] [Related]
4. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
[TBL] [Abstract][Full Text] [Related]
5. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines.
Ouakad M; Vanaerschot M; Rijal S; Sundar S; Speybroeck N; Kestens L; Boel L; De Doncker S; Maes I; Decuypere S; Dujardin JC
Parasitology; 2011 Sep; 138(11):1392-9. PubMed ID: 21819638
[TBL] [Abstract][Full Text] [Related]
6. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
Sinha R; Roychoudhury J; Palit P; Ali N
Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907
[TBL] [Abstract][Full Text] [Related]
7. Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.
Roychoudhury J; Sinha R; Ali N
PLoS One; 2011 Mar; 6(3):e17376. PubMed ID: 21423750
[TBL] [Abstract][Full Text] [Related]
8. Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.
Berg M; García-Hernández R; Cuypers B; Vanaerschot M; Manzano JI; Poveda JA; Ferragut JA; Castanys S; Dujardin JC; Gamarro F
Antimicrob Agents Chemother; 2015 Apr; 59(4):2242-55. PubMed ID: 25645828
[TBL] [Abstract][Full Text] [Related]
9. Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase.
Carter KC; Hutchison S; Henriquez FL; Légaré D; Ouellette M; Roberts CW; Mullen AB
Antimicrob Agents Chemother; 2006 Jan; 50(1):88-95. PubMed ID: 16377672
[TBL] [Abstract][Full Text] [Related]
10. Linking in vitro and in vivo survival of clinical Leishmania donovani strains.
Vanaerschot M; Maes I; Ouakad M; Adaui V; Maes L; De Doncker S; Rijal S; Chappuis F; Dujardin JC; Decuypere S
PLoS One; 2010 Aug; 5(8):e12211. PubMed ID: 20808916
[TBL] [Abstract][Full Text] [Related]
11. Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
Carter KC; Hutchison S; Boitelle A; Murray HW; Sundar S; Mullen AB
Parasitology; 2005 Dec; 131(Pt 6):747-57. PubMed ID: 16336728
[TBL] [Abstract][Full Text] [Related]
12. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.
Carter KC; Mullen AB; Sundar S; Kenney RT
Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339
[TBL] [Abstract][Full Text] [Related]
13. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
Pal S; Mandal A; Duttagupta S
Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
Valiathan R; Dubey ML; Mahajan RC; Malla N
Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
[TBL] [Abstract][Full Text] [Related]
15. Activity of rutin, a potent flavonoid against SSG-sensitive and -resistant Leishmania donovani parasites in experimental leishmaniasis.
Chauhan K; Kaur G; Kaur S
Int Immunopharmacol; 2018 Nov; 64():372-385. PubMed ID: 30245348
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the proliferating cell nuclear antigen of Leishmania donovani clinical isolates and its association with antimony resistance.
Tandon R; Chandra S; Baharia RK; Das S; Misra P; Kumar A; Siddiqi MI; Sundar S; Dube A
Antimicrob Agents Chemother; 2014 Jun; 58(6):2997-3007. PubMed ID: 24614385
[TBL] [Abstract][Full Text] [Related]
17. The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis.
Carter KC; Sundar S; Spickett C; Pereira OC; Mullen AB
Antimicrob Agents Chemother; 2003 May; 47(5):1529-35. PubMed ID: 12709318
[TBL] [Abstract][Full Text] [Related]
18. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.
Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G
mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics to unveil and understand phenotypic diversity between pathogen populations.
t'Kindt R; Scheltema RA; Jankevics A; Brunker K; Rijal S; Dujardin JC; Breitling R; Watson DG; Coombs GH; Decuypere S
PLoS Negl Trop Dis; 2010 Nov; 4(11):e904. PubMed ID: 21152055
[TBL] [Abstract][Full Text] [Related]
20. Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent.
Vanaerschot M; Decuypere S; Downing T; Imamura H; Stark O; De Doncker S; Roy S; Ostyn B; Maes L; Khanal B; Boelaert M; Schönian G; Berriman M; Chappuis F; Dujardin JC; Sundar S; Rijal S
J Infect Dis; 2012 Sep; 206(5):752-5. PubMed ID: 22753945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
